The Asia-Pacific geriatric medicine market is projected to witness a CAGR of 6.8% during the forecast period. The major factors contributing to the growth of the market include the increasing geriatric population and rising prevalence of chronic diseases, such as cardiovascular diseases (CVDs) and cancer. Moreover, the rising industrial sector in these Asia-Pacific economies is further increasing the pollution level and the prevalence of respiratory and other disorders in the geriatric population. These factors combinedly offering growth to the geriatric medicine market in the region.
To Request a Sample of our Report on Asia-Pacific Geriatric Medicine Market: https://www.omrglobal.com/request-sample/asia-pacific-geriatric-medicine-market
The geriatric medicine market is classified on the basis of therapeutics and conditions. Based on therapeutics, the market is segmented into analgesic, anticoagulant, antihypertensive, antidiabetic, and others. Based on the condition, the market is segregated into CVDs, diabetes, neurological, cancer, respiratory, and others. Among these conditions, the CVDs segment contributes significantly to the market. The significant contribution of the segment is backed by the significant patient pool of CVDs in the region. With the rise in age, the development of CVDs increases subsequently. Therefore, a huge market is covered by CVDs medicines in the geriatric medicine market.
Geographically, Asia-Pacific geriatric medicine market is analyzed for China, Japan, India, and the Rest of Asia-Pacific. China contributed the major share in Asia-Pacific geriatric medicine market in 2019 and is expected to retain its position during the forecast period. The dominance of China in the Asia-Pacific market is mainly due to the presence of a substantial health workforce in the country. India is projected to exhibit a considerable CAGR in Asia-Pacific geriatric medicine market during the forecast period, owing to the rising geriatric population and expansion of global market players in the country.
A full Report of Asia-Pacific Geriatric Medicine Market is Available @ https://www.omrglobal.com/industry-reports/asia-pacific-geriatric-medicine-market
Asia-Pacific Geriatric Medicine Market Segmentation
By Therapeutic
- Analgesic
- Anticoagulant
- Antihypertensive
- Antidiabetic
- Others (Statins and Antipsychotic)
By Condition
- Cardiovascular Diseases (CVDs)
- Diabetes
- Neurological
- Cancer
- Respiratory
- Others (Arthritis and Osteoporosis)
Regional Analysis
- China
- India
- Japan
- ASEAN
- South Korea
Rest of Asia Pacific
Company Profiles
- Abbott Laboratories Inc.
- Overview
- Abbott Laboratories in Asia-Pacific
- Abbott Laboratories in Geriatric Medicine Landscape
- Recent Developments
- Amgen Inc.
- Astellas Pharma Inc.
- AstraZeneca PLC
- Aurobindo Pharma Ltd.
- Boehringer Ingelheim GmbH
- Bristol-Myers Squibb Co.
- Cipla Ltd.
- Eli Lilly and Co.
- GlaxoSmithKline PLC
- Johnson & Johnson Services Inc.
- Mankind Pharma
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi SA
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
